** Shares of drug developer Edesa Biotech EDSA.O surge 68.9% to $3.1 in morning trade
** EDSA says it is raising $15 million from private placement of shares
** Co says it will use the proceeds towards a mid-stage trial evaluating its experimental treatment EB06 in patients with nonsegmental vitiligo, a chronic skin disorder that causes patches and loss of skin color
** Co says shares were offered directly to the investors without a placement agent, underwriter, broker or dealer
** Co has 3.47 mln outstanding shares and market value of $6.45 mln - LSEG data
** Stock fell ~69% in the last 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。